TACTOSET

Our portfolio of orthopedic regenerative solutions is driven by our proprietary HA technologies. These products include Tactoset, an HA-enhanced injectable bone void filler designed to treat insufficiency fractures and augment hardware fixation, such as suture anchors, available in the US, and Hyalofast, an off-the-shelf, single stage, HA-based fiber scaffold used to support cartilage regeneration, available in more than 30 countries outside the US... With over 30 years of global expertise developing, manufacturing and commercializing products based on hyaluronic acid (HA), a naturally occurring polymer found throughout the body and vital for proper joint health and tissue function, we are a leader in viscosupplement injectables for osteoarthritis (OA) pain management. Our key OA pain viscosupplement products include Orthovisc and Monovisc, which are exclusively marketed and sold in the US through the DePuy Synthes division of Johnson and Johnson and outside the US by Anika and our..

Also known as: Anika Therapeutics, Anika Therapeutics, Inc.

Primary location: Bedford United States